Literature DB >> 23666965

Expression and function of the progesterone receptor in human prostate stroma provide novel insights to cell proliferation control.

Yue Yu1, Liangliang Liu, Ning Xie, Hui Xue, Ladan Fazli, Ralph Buttyan, Yuzhuo Wang, Martin Gleave, Xuesen Dong.   

Abstract

CONTEXT: Like other tissues, the prostate is an admixture of many different cell types that can be segregated into components of the epithelium or stroma. Reciprocal interactions between these 2 types of cells are critical for maintaining prostate homeostasis, whereas aberrant stromal cell proliferation can disrupt this balance and result in diseases such as benign prostatic hyperplasia. Although the androgen and estrogen receptors are relatively well studied for their functions in controlling stromal cell proliferation and differentiation, the role of the progesterone receptor (PR) remains unclear.
OBJECTIVE: The aim of the study was to investigate the expression and function of the PR in the prostate. DESIGN AND
SETTING: Human prostate biopsies, renal capsule xenografts, and prostate stromal cells were used. Immunohistochemistry, Western blotting, real-time quantitative PCR, cell proliferation, flow cytometry, and gene microarray analyses were performed.
RESULTS: Two PR isoforms, PRA and PRB, are expressed in prostate stromal fibroblasts and smooth muscle cells, but not in epithelial cells. Both PR isoforms suppress prostate stromal cell proliferation through inhibition of the expression of cyclinA, cyclinB, and cdc25c, thus delaying cell cycling through S and M phases. Gene microarray analyses further demonstrated that PRA and PRB regulated different transcriptomes. However, one of the major gene groups commonly regulated by both PR isoforms was the one associated with regulation of cell proliferation.
CONCLUSION: PR plays an inhibitory role in prostate stromal cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23666965      PMCID: PMC4078099          DOI: 10.1210/jc.2012-4000

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

Review 1.  Estrogen and androgen signaling in the pathogenesis of BPH.

Authors:  Clement K M Ho; Fouad K Habib
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

2.  Progesterone is essential for maintenance and growth of uterine leiomyoma.

Authors:  Hiroshi Ishikawa; Kazutomo Ishi; Vanida Ann Serna; Rafael Kakazu; Serdar E Bulun; Takeshi Kurita
Journal:  Endocrinology       Date:  2010-04-07       Impact factor: 4.736

3.  Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform.

Authors:  B Mulac-Jericevic; R A Mullinax; F J DeMayo; J P Lydon; O M Conneely
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

Review 4.  Endocrine and paracrine regulation of birth at term and preterm.

Authors:  S G Matthews; W Gibb; S J Lye
Journal:  Endocr Rev       Date:  2000-10       Impact factor: 19.871

5.  Progesterone receptor expression in human prostate cancer: correlation with tumor progression.

Authors:  H Bonkhoff; T Fixemer; I Hunsicker; K Remberger
Journal:  Prostate       Date:  2001-09-15       Impact factor: 4.104

6.  The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.

Authors:  P H Giangrande; E A Kimbrel; D P Edwards; D P McDonnell
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

7.  Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.

Authors:  A Latil; I Bièche; D Vidaud; R Lidereau; P Berthon; O Cussenot; M Vidaud
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

8.  Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms.

Authors:  Daniel B Hardy; Bethany A Janowski; Chien-Cheng Chen; Carole R Mendelson
Journal:  Mol Endocrinol       Date:  2008-05-15

Review 9.  Integrated actions of progesterone receptor and cell cycle machinery regulate breast cancer cell proliferation.

Authors:  Gwen E Dressing; Carol A Lange
Journal:  Steroids       Date:  2008-12-11       Impact factor: 2.668

Review 10.  The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression.

Authors:  Viroj Boonyaratanakornkit; Yan Bi; Michael Rudd; Dean P Edwards
Journal:  Steroids       Date:  2008-01-19       Impact factor: 2.668

View more
  23 in total

Review 1.  Androgen receptor splice variants in the era of enzalutamide and abiraterone.

Authors:  Mary Nakazawa; Emmanuel S Antonarakis; Jun Luo
Journal:  Horm Cancer       Date:  2014-07-22       Impact factor: 3.869

2.  Decreased expression of stromal estrogen receptor α and β in prostate cancer.

Authors:  Garrett Daniels; Lan Lin Gellert; Jonathan Melamed; David Hatcher; Yirong Li; Jianjun Wei; Jinhua Wang; Peng Lee
Journal:  Am J Transl Res       Date:  2014-01-15       Impact factor: 4.060

3.  Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia.

Authors:  Lingmin Song; Wenhao Shen; Heng Zhang; Qiwu Wang; Yongquan Wang; Zhansong Zhou
Journal:  Bosn J Basic Med Sci       Date:  2016-06-13       Impact factor: 3.363

Review 4.  Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer.

Authors:  Philip A Watson; Vivek K Arora; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2015-11-13       Impact factor: 60.716

5.  Oleuropein is a natural inhibitor of PAI-1-mediated proliferation in human ER-/PR- breast cancer cells.

Authors:  Elena E Tzekaki; George Geromichalos; Sophia N Lavrentiadou; Maria P Tsantarliotou; Anastasia A Pantazaki; Angelos Papaspyropoulos
Journal:  Breast Cancer Res Treat       Date:  2021-01-03       Impact factor: 4.872

6.  Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression.

Authors:  Haolong Li; Ning Xie; Martin E Gleave; Xuesen Dong
Journal:  Oncotarget       Date:  2015-08-21

7.  Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells.

Authors:  Liangliang Liu; Xuesen Dong
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

8.  High progesterone receptor expression in prostate cancer is associated with clinical failure.

Authors:  Thea Grindstad; Sigve Andersen; Samer Al-Saad; Tom Donnem; Yury Kiselev; Christian Nordahl Melbø-Jørgensen; Kaja Skjefstad; Lill-Tove Busund; Roy M Bremnes; Elin Richardsen
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

9.  Prostate stromal cells express the progesterone receptor to control cancer cell mobility.

Authors:  Yue Yu; Jennifer Suehyun Lee; Ning Xie; Estelle Li; Antonio Hurtado-Coll; Ladan Fazli; Michael Cox; Stephen Plymate; Martin Gleave; Xuesen Dong
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

10.  The androgen receptor mediates antiapoptotic function in myometrial cells.

Authors:  H Li; Y Li; D Morin; S Plymate; S Lye; X Dong
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.